Karin Schaeuble
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: June 24, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.
Journal: Science immunology
Published: June 05, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 29, 2026
Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 29, 2026
MYCT1-IFITM2/3 interaction links endothelial endolysosomal trafficking to white adipose tissue expansion.
Journal: The Journal of experimental medicine
Published: July 22, 2025
Inhibition of Cbl-b restores effector functions of human intratumoral NK cells.
Journal: Journal for immunotherapy of cancer
Published: October 24, 2024
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia.
Journal: Cell death & disease
Published: June 22, 2021
Intratumoral CD8+ T cells with stem cell-like properties: Implications for cancer immunotherapy.
Journal: Science translational medicine
Published: July 10, 2019
Attenuation of chronic antiviral T-cell responses through constitutive COX2-dependent prostanoid synthesis by lymph node fibroblasts.
Journal: PLoS biology
Published: October 22, 2018
Last Updated: 09/26/2026